[1]
M. Todorović Balint, “Influence of applied CD34+ cell dose on the survival of Hodgkin’s lymphoma and multiple myeloma patients following autologous stem cell transplants”, Vojnosanit Pregl, vol. 77, no. 8, Apr. 2021, doi: 10.2298/VSP180808160T.